Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Colorectal Neoplasms
Interventions: Drug: Glutamine; Drug: Calcium and Magnesium
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Neoplasms, Malignant
Intervention: Drug: Cabazitaxel (XRP6258)
Sponsor: Sanofi-Aventis
Not yet recruiting - verified March 2010
Condition: Non-small Cell Lung Cancer Stage IV
Interventions: Drug: SAR240550 (BSI-201); Drug: gemcitabine; Drug: cisplatin
Sponsor: Sanofi-Aventis
Not yet recruiting - verified March 2010
Conditions: Influenza; Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated); Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Hematological Malignancy
Intervention: Drug: SAR650984
Sponsor: Sanofi-Aventis
Not yet recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention: Drug: Exenatide, Insulin Glargine or Exenatide + Insulin Glargine
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Sanofi-Aventis
Not yet recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE; Drug: INSULIN GLULISINE
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Conditions: Meningococcal Infection; Meningitis
Intervention: Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)
Sponsor: Sanofi-Aventis
Not yet recruiting - verified March 2010
Condition: Ataxia Telangiectasia
Interventions: Biological: Prevenar® (7-valent pneumococcal conjugate vaccine); Biological: Pneumovax® (pneumococcal polysaccharide vaccine)
Sponsor: Sheba Medical Center
Not yet recruiting - verified March 2010
Condition: Prostatic Neoplasms
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Condition: Peripheral Vascular Diseases
Intervention:
Sponsors: Sanofi-Aventis; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin glulisine; Drug: Insulin glargine; Drug: Premixed insulin (Insulin Aspart 30/70 )
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Acute Coronary Syndrome
Interventions: Drug: eptifibatide; Drug: unfractionated heparin placebo; Drug: unfractionated heparin; Drug: otamixaban (XRP0673); Drug: eptifibatide placebo; Drug: otamixaban placebo
Sponsor: Sanofi-Aventis
Not yet recruiting - verified February 2010
Condition: Squamous Cell Lung Cancer
Interventions: Drug: gemcitabine/carboplatin; Drug: gemcitabine/carboplatin plus BSI-201
Sponsors: BiPar Sciences; Sanofi-Aventis
Recruiting - verified March 2010
Condition: Pertussis
Intervention:
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Intra-Abdominal Hypertension
Intervention: Drug: furosemide
Sponsor: Ziekenhuis Netwerk Antwerpen (ZNA)
Recruiting - verified February 2010
Condition: Healthy
Interventions: Biological: REGN727; Biological: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi-Aventis
Not yet recruiting - verified February 2010
All Categories ... Pharma Companies » ... Sanofi-Aventis 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
